Login to Your Account



Charleston Ends Phase III Early: Opioid-Nausea Therapy Works

By Randy Osborne
Staff Writer

Wednesday, October 30, 2013
Although opioid-induced constipation (OIC) has gotten most of the press in recent years, Charleston Laboratories Inc. may be about to change all that, given Phase III success with CL-108, which provides the pain relief of hydrocodone without the side effects that are even more prevalent: nausea and vomiting (OINV).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription